Korea Fixed-Income Investment Advisory

Corporation · Biz. reg. 107-87-***** · 8 stocks

Value held (filed)$74M8 direct holdings

30-day net+$8.5MAdded $8.5M · Reduced $0

30-day trades

Reduced 0

Added 2$7.4MHwail Pharm +12.53pp $1.1MEnbioco +6.22pp

Calculated from quantities and prices in the filings, or the closing price where a filing omits prices (short-form filings such as the NPS). A change reported in both a 5% filing and an insider filing is counted once

Holdings

Value Stake Latest filing

Osung Advanced Materialsdirect 5.82%5.82%$31M N2TECHdirect 13.08%13.08%$21M MKElectrondirect 4.43%4.43%$7.9M

Hwail Pharmdirect 12.53% · indirect 1.71%14.24%$5.4M

Direct12.53%
Osung Advanced Materials 5.82% → Rftech 31.13% → Kumho HT 33.71% → Hwail Pharm 10.92%0.07%
Osung Advanced Materials 5.82% → Hwail Pharm 26.20%1.52%
Osung Advanced Materials 5.82% → Kumho HT 18.56% → Hwail Pharm 10.92%0.12%

Atlas Linkdirect 24.21%24.21%$5.1M DH Autoleaddirect 10.68%10.68%$2.7M Enbiocodirect 6.22%6.22%$1.1M Poongjeon Pharmacydirect 6.36%6.36%$947K

11 indirect-only holdings

No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.

Korea Real Estate Investment & Trustindirect 0.50%0.50%$892K

MKElectron 4.43% → Korea Real Estate Investment & Trust 11.21%0.50%

Kumho HTindirect 1.69%1.69%$800K

Osung Advanced Materials 5.82% → Rftech 31.13% → Kumho HT 33.71%0.61%
Osung Advanced Materials 5.82% → Kumho HT 18.56%1.08%

Rftechindirect 1.81%1.81%$782K

Osung Advanced Materials 5.82% → Rftech 31.13%1.81%

Indirect stakes multiply ownership through listed companies. Stakes through unlisted companies and holdings under 5% are not filed. Values overlap through subsidiaries, so do not add them up.

KKorea Fixed-Income Investment Advisory

30-day trades

Holdings

Korea Fixed-Income Investment Advisory